样式: 排序: IF: - GO 导出 标记为已读
-
Surgical outcomes and predictive value for major complications of robot‐assisted radical cystectomy of real‐world data in a single institution in Japan Int. J. Urol. (IF 2.6) Pub Date : 2024-03-13 Yosuke Yasuda, Noboru Numao, Ryo Fujiwara, Kosuke Takemura, Yusuke Yoneoka, Tomohiko Oguchi, Shinya Yamamoto, Junji Yonese
ObjectiveThe objective of the study was to describe the surgical outcome of robot‐assisted radical cystectomy and predictive factors for major complications in real‐world clinical practice at a single institution in Japan.MethodsWe retrospectively analyzed 208 consecutive patients undergoing robot‐assisted radical cystectomy at our institution between 2019 and 2023. Patient and disease characteristics
-
Downregulation of miR‐211 expression in the blood plasma of infertile men compared to the fertile controls Int. J. Urol. (IF 2.6) Pub Date : 2024-03-12 Nasim Naeimi, Homa MohseniKouchesfehani, Hamidreza Mahmoudzadeh‐Sagheb, Saeed Movahed, Bita Moudi, Azam Asemirad, Nadia Sheibak, Zahra Heidari
ObjectivesInfertility is inability to conceive after 12 months of regular unprotected sex. MiRNA expression changes can serve as potential biomarkers for infertility in males due to impaired spermatogenesis. This research was conducted to measure the expression level of miR‐211 in plasma samples as a factor identifying infertility in comparison with the control group.MethodsIn this study, blood plasma
-
The relevance of circRNAs in serum of patients undergoing prostate biopsy Int. J. Urol. (IF 2.6) Pub Date : 2024-03-12 Fumihiko Urabe
-
Endovascular aortic protection prior to retroperitoneal lymph node dissection for testicular cancer Int. J. Urol. (IF 2.6) Pub Date : 2024-03-12 Shinya Miyazaki, Takashi Ueda, Masayoshi Okumi, Hidetake Kawajiri, Keiichi Kanda, Osamu Ukimura
CONFLICT OF INTEREST STATEMENT The authors declare no conflicts of interest.
-
Real‐world epidemiology and treatment patterns of patients with locally advanced or metastatic urothelial carcinoma: Retrospective analysis of Diagnosis Procedure Combination claims data in Japan Int. J. Urol. (IF 2.6) Pub Date : 2024-03-12 Keiko Asakawa, Miina Waratani, Olivia Massey, Tim Holbrook, Makoto Kondo, Atsushi Saito, Hiroyuki Nishiyama
ObjectivesEvaluate real‐world epidemiologic trends and treatment patterns in newly diagnosed patients with locally advanced or metastatic urothelial carcinoma (la/mUC) in Japan.MethodsThis retrospective analysis included adults with newly diagnosed la/mUC in Japan (January 2015–December 2019) from a nationwide‐linked electronic medical record Diagnostic Procedure Combination claims dataset. Outcomes
-
Utility of positive core number on MRI‐ultrasound fusion targeted biopsy in combination with PI‐RADS scores for predicting unexpected extracapsular extension of clinically localized prostate cancer Int. J. Urol. (IF 2.6) Pub Date : 2024-03-12 Masaki Kobayashi, Yoh Matsuoka, Sho Uehara, Hiroshi Tanaka, Motohiro Fujiwara, Yuki Nakamura, Yudai Ishikawa, Shohei Fukuda, Yuma Waseda, Hajime Tanaka, Soichiro Yoshida, Yasuhisa Fujii
ObjectivesTo evaluate the utility of magnetic resonance imaging (MRI) and MRI‐ultrasound fusion targeted biopsy (TB) for predicting unexpected extracapsular extension (ECE) in clinically localized prostate cancer (CLPC).MethodsThis study enrolled 89 prostate cancer patients with one or more lesions showing a Prostate Imaging‐Reporting and Data System (PI‐RADS) score ≥3 but without morphological abnormality
-
Intrinsic and extrinsic factors causing hyperplasia of the prostate Int. J. Urol. (IF 2.6) Pub Date : 2024-03-11 Yuki Kyoda, Kosuke Shibamori, Tetsuya Shindo, Takeshi Maehana, Kohei Hashimoto, Ko Kobayashi, Toshiaki Tanaka, Fumimasa Fukuta, Naoya Masumori
Prostatic hyperplasia is very common in elderly men and is a typical disease that reduces quality of life. Histologically, hyperplasia of the prostate gland causes obstruction at the bladder outlet, resulting in symptoms such as a weak urine stream. Various factors have been considered to cause histological enlargement of the prostate, but the underlying cause is still unknown. The factors that cause
-
-
This issue 31‐3 Int. J. Urol. (IF 2.6) Pub Date : 2024-03-10 Tomohiko Ichikawa
CONFLICT OF INTEREST STATEMENT None declared.
-
Editorial Comment on Exploring androgen receptor signaling pathway in prostate cancer: A path to new discoveries Int. J. Urol. (IF 2.6) Pub Date : 2024-03-08 Yusuke Goto
CONFLICT OF INTEREST STATEMENT The author declares no conflict of interest.
-
Efficacy and safety of combination neoadjuvant chemo‐hormonal therapy and robot‐assisted radical prostatectomy for oligometastatic prostate cancer Int. J. Urol. (IF 2.6) Pub Date : 2024-03-08 Makoto Kawase, Daiki Kato, Yuki Tobisawa, Koji Iinuma, Keita Nakane, Takuya Koie
Previously, most patients with metastatic castration-sensitive prostate cancer (mCSPC) received hormone therapy, including androgen deprivation therapy (ADT). In a retrospective study using the Surveillance Epidemiology and End Results database, patients with mCSPC and oligometastases (Oligo-PCa) who underwent radical prostatectomy (RP) or brachytherapy experienced prolonged overall survival (OS) compared
-
Survival beyond cabazitaxel for metastatic castration‐resistant prostate cancer Int. J. Urol. (IF 2.6) Pub Date : 2024-03-05 Leandro Blas, Masaki Shiota, Tokiyoshi Tanegashima, Satoshi Kobayashi, Takashi Matsumoto, Masatoshi Eto
CONFLICT OF INTEREST STATEMENT Masaki Shiota received honoraria from Janssen Pharmaceutical, AstraZeneca, Sanofi, Bayer Yakuhin, and Astellas Pharma, and research funding support from Daiichi Sankyo. Masatoshi Eto received honoraria from Ono Pharmaceutical, Takeda Pharmaceutical, Novartis Pharma, Pfizer, Bristol-Myers Squibb, Janssen Pharmaceutical, MSD, and Merck Biopharma, and research funding support
-
Comparison of the perioperative outcomes of using the Firefly system with indocyanine green during robotic‐assisted cystectomy with urinary diversion Int. J. Urol. (IF 2.6) Pub Date : 2024-03-01 Hangcheng Fu, Emily Hillman, Sriharsha Talluri, Lifan Liang, Said Mohammed, Jamie Messer
IntroductionUse of indocyanine green (ICG) with near‐infrared fluorescence (NIRF) has been demonstrated to be an effective tool for intraoperative assessment of bowel and ureteric vascularity. This study aimed to evaluate the impact of ICG on postsurgical outcomes such as anastomotic bowel leak and uretero‐enteric stricture formation during robot‐assisted cystectomy (RAC) and intracorporeal urinary
-
Clinical outcomes in patients with advanced urothelial carcinoma treated with enfortumab vedotin: A retrospective multicenter study in Japan Int. J. Urol. (IF 2.6) Pub Date : 2024-03-01 Takuto Hara, Yuto Matsushita, Kenichi Harada, Naohiro Fujimoto, Masato Fujisawa, Hideaki Miyake
CONFLICT OF INTEREST STATEMENT None declared.
-
Editorial Comment to Real‐world sequential treatment patterns and clinical outcomes among patients with advanced urothelial carcinoma in Japan Int. J. Urol. (IF 2.6) Pub Date : 2024-03-01 Tsunenori Kondo
CONFLICT OF INTEREST STATEMENT Tsunenori Kondo received honoraria from Pfizer, MSD, Takeda Pharmaceutical Company, and Ono Pharmaceutical.
-
Editorial Comment to The DDD score outperforms the RENAL score in predicting high‐grade renal cell carcinoma Int. J. Urol. (IF 2.6) Pub Date : 2024-02-28 Hiroki Ishihara, Toshio Takagi
CONFLICT OF INTEREST STATEMENT None.
-
Significant reduction in left testicular volume shown by ultrasonography in infertile patients with left‐side grade 2–3 varicocele as compared to less than grade 2: An evidence for indication of varicocelectomy Int. J. Urol. (IF 2.6) Pub Date : 2024-02-25 Nobuyuki Kondoh, Ai Chikawa, Mikiko Okumura, Hitomi Hayakawa, Naoko Ohama, Minoru Shigeta
PurposeTesticular volume (TV) is known to be one of the main parameters for testicular function (TF). This study was conducted to re‐evaluate the indications of a varicocelectomy based on a survey of preoperative TV results in left‐side varicocele patients considered to reflect the detrimental effects of a varicocele on TF.MethodsTV results of infertile patients determined using ultrasonography by
-
The significance of G8 and other geriatric assessments in urologic cancer management: A comprehensive review Int. J. Urol. (IF 2.6) Pub Date : 2024-02-25 Shugo Yajima, Hitoshi Masuda
In urologic oncology, which often involves older patients, it is important to consider how to manage their care appropriately. Geriatric assessment (GA) is a method that can address the specific needs of older cancer patients. The GA encompasses various assessment domains, but these domains exhibit variations across the literature. Some of the common items include functional ability, nutrition, comorbidities
-
Enfortumab vedotin prolongs overall survival in metastatic urothelial carcinoma following pembrolizumab therapy in real‐world data Int. J. Urol. (IF 2.6) Pub Date : 2024-02-25 Koichi Uemura, Hiroki Ito, Ryosuke Jikuya, Takuya Kondo, Tomoyuki Tatenuma, Takashi Kawahara, Yusuke Ito, Mitsuru Komeya, Kentaro Muraoka, Hisashi Hasumi, Hiroji Uemura, Kazuhide Makiyama
ObjectiveIn December 2021, enfortumab vedotin (EV), an antibody‐drug conjugate directed against nectin‐4, was approved in Japan as a new treatment after platinum‐containing chemotherapy and PD‐1/PD‐L1 inhibitors. This study evaluated, using real‐world data, the efficacy and safety of EV therapy in patients with metastatic urothelial carcinoma (mUC).Materials and methodsFifty‐five patients with mUC
-
Editorial Comment on Two‐year follow‐up comparing Rezūm therapy versus bipolar transurethral resection of the prostate for treating benign prostatic hyperplasia: A prospective randomized study Int. J. Urol. (IF 2.6) Pub Date : 2024-02-23 Taiki Kato
CONFLICT OF INTEREST STATEMENT None declared.
-
Chromogranin A as a diagnostic marker of pheochromocytoma and paraganglioma: A systematic review and meta‐analysis Int. J. Urol. (IF 2.6) Pub Date : 2024-02-21 Yanbo Xing, Haoying Shi, Qiang Guo, Cong Wang, Chengyong Li, Chuan Hao
ObjectivesThis work aims to assess the diagnostic value of chromogranin A (CgA) in the laboratory diagnosis of neuroendocrine tumors classified as pheochromocytoma and paraganglioma (PPGL).MethodsA comprehensive search was performed in PubMed, Embase, the Cochrane Library, and Web of Science databases to obtain relevant studies reporting the diagnostic accuracy of CgA in patients with PPGL. The search
-
Gap analysis between trainees' subjective competencies and the competencies expected by instructors in urology: A need assessment survey in Japan Int. J. Urol. (IF 2.6) Pub Date : 2024-02-17 Kanta Hori, Takashige Abe, Noriyuki Abe, Junya Abe, Kazufumi Okada, Keita Takahashi, Shigeru Harada, Jun Furumido, Sachiyo Murai, Masafumi Kon, Kohei Hashimoto, Naoya Masumori, Hidehiro Kakizaki, Nobuo Shinohara
According to the rapid progress in surgical techniques, a growing number of procedures should be learned during postgraduate training periods. This study aimed to clarify the current situation regarding urological surgical training and identify the perception gap between trainees' competency and the competency expected by instructors in Japan.
-
Editorial Comment on Real-world sequential treatment patterns and clinical outcomes among patients with advanced urothelial carcinoma in Japan Int. J. Urol. (IF 2.6) Pub Date : 2024-02-17 Hiroki Ishihara, Toshio Takagi
CONFLICT OF INTEREST STATEMENT None.
-
Delayed treatment with erythropoietin attenuates renal fibrosis in mouse model of unilateral ureteral obstruction Int. J. Urol. (IF 2.6) Pub Date : 2024-02-17 Akihiro Nishida, Masashi Nishida, Tomoko Iehara
Erythropoietin (EPO) exerts tissue-protective effects on various organs including the kidney. However, the effects of EPO on established renal fibrosis remain unclear. In this study, we aimed to examine the therapeutic potential of EPO against established renal fibrosis.
-
Current status and future perspectives on robot-assisted kidney autotransplantation: A literature review Int. J. Urol. (IF 2.6) Pub Date : 2024-02-17 Takanori Sekito, Tomoaki Yamanoi, Takuya Sadahira, Kasumi Yoshinaga, Yuki Maruyama, Yusuke Tominaga, Satoshi Katayama, Takehiro Iwata, Shingo Nishimura, Kensuke Bekku, Kohei Edamura, Tomoko Kobayashi, Yasuyuki Kobayashi, Motoo Araki
This review presents the latest insights on robot-assisted kidney autotransplantation (RAKAT). RAKAT is a minimally invasive surgical procedure and represents a promising alternative to conventional laparoscopic nephrectomy followed by open kidney transplantation for the treatment of various complex urological and vascular conditions. RAKAT can be performed either extracorporeally or intracorporeally
-
The relevance of circRNAs in serum of patients undergoing prostate biopsy Int. J. Urol. (IF 2.6) Pub Date : 2024-02-16 Lara Samirae, Philipp Krausewitz, Abdullah Alajati, Glen Kristiansen, Manuel Ritter, Jörg Ellinger
First discovered in the 1970s, circular RNAs (circRNAs) were considered as unimportant RNA splicing products. circRNAs are described as a stable type of endogenous non-coding RNA, which is synthesized by back-splicing of the precursor mRNA (pre-mRNA). circRNAs consist of a loop structure with covalent bonds of head and tail. Lacking a 3′ end, circRNAs are more resistant to digestion by exonucleases
-
Editorial Comment on Longitudinal mortality risks and kidney functional outcomes in Japanese living kidney donors Int. J. Urol. (IF 2.6) Pub Date : 2024-02-15 Masayoshi Okumi
CONFLICT OF INTEREST STATEMENT The author of the editorial comment has no conflict of interest.
-
Does radical cystectomy have a better prognosis than bladder conservative treatment in the real world? Int. J. Urol. (IF 2.6) Pub Date : 2024-02-15 Ryunosuke Nakagawa, Kouji Izumi, Ren Toriumi, Shuhei Aoyama, Taiki Kamijima, Tomoyuki Makino, Renato Naito, Hiroaki Iwamoto, Hiroshi Yaegashi, Shohei Kawaguchi, Kazuyoshi Shigehara, Takahiro Nohara, Atsushi Mizokami
To compare the prognosis and quality of life between radical cystectomy and bladder conservative treatment for muscle invasive bladder cancer in the real world.
-
Editorial comment on Differences in overall survival of penile cancer patients vs. population-based controls Int. J. Urol. (IF 2.6) Pub Date : 2024-02-13 Eric Chung, Brian Ng Hung Shin, Juan Wang
While penile cancer is considered a rare genitourinary cancer, it is predicted to become more prevalent in the coming decades.1 Published data from national databases and clinical registries have highlighted significant gaps in the diagnosis and management of penile cancer due to geographical differences in its prevalence and survival patterns, and more studies are required to comprehensively analyze
-
Significance of atypical nodules upgraded to category 3 in Prostate Imaging Reporting and Data System version 2.1 for prostate cancer diagnosis Int. J. Urol. (IF 2.6) Pub Date : 2024-02-12 Shintaro Asai, Masaki Kobayashi, Shohei Fukuda, Koichiro Kimura, Soichiro Yoshida, Yasuhisa Fujii
CONFLICT OF INTEREST STATEMENT The authors have no conflicts of interest to declare.
-
Exploring androgen receptor signaling pathway in prostate cancer: A path to new discoveries Int. J. Urol. (IF 2.6) Pub Date : 2024-02-12 Daisuke Obinata, Kenichi Takayama, Satoshi Inoue, Satoru Takahashi
Androgen deprivation therapy has achieved significant success in treating prostate cancer through strategies centered on the androgen receptor. However, the emergence of castration-resistant prostate cancer highlights this therapy limitation, underscoring the need to elucidate the mechanisms of treatment resistance. This review aimed to focus on multifaceted resistance mechanisms, including androgen
-
A nomogram for predicting risk factors of testicular salvage after testicular torsion in children Int. J. Urol. (IF 2.6) Pub Date : 2024-02-10 Pengyu Chen, Weipeng Huang, Yingying He, Mengkui Sun, Xuerui Sun, Yiyan Huang, Shoulin Li
This study aimed to establish a nomogram for predicting the probability of testicular salvage after testicular torsion in children.
-
Comparison of patient background between a real-world North American cohort and the Göteborg-2 trial Int. J. Urol. (IF 2.6) Pub Date : 2024-02-09 Giuseppe Chiarelli, Matthew Davis, Alex Stephens, Giuseppe Ottone Cirulli, Marco Finati, Nicholas J. Corsi, Akshay Sood, Shane Tinsley, Giuseppe Carrieri, Alberto Briganti, Francesco Montorsi, Giovanni Lughezzani, Nicolò Buffi, Craig Rogers, Firas Abdollah
To analyze the generalizability of the Göteborg-2 findings to a North American cohort.
-
Editorial Comments on The harmful effects of overlooking acute bacterial prostatitis Int. J. Urol. (IF 2.6) Pub Date : 2024-02-01 Tomohiro Matsuo, Ryoichi Imamura
CONFLICT OF INTEREST STATEMENT None declared.
-
This issue 31-2 Int. J. Urol. (IF 2.6) Pub Date : 2024-02-03 Hiroyuki Nishiyama
CONFLICT OF INTEREST STATEMENT None declared.
-
Editorial Comment on Prognostic outcomes in patients with metastatic renal cell carcinoma receiving second-line treatment with tyrosine kinase inhibitor following first-line immune-oncology combination therapy Int. J. Urol. (IF 2.6) Pub Date : 2024-02-01 Hiroki Ishihara, Toshio Takagi
CONFLICT OF INTEREST STATEMENT Toshio Takagi received honoraria from Pfizer, Novartis, and Bristol-Myers Squibb and Ono Pharmaceutical.
-
Editorial Comment on Variant histology is associated with more non-urothelial tract recurrence but less intravesical recurrence for upper tract urothelial carcinoma after radical nephroureterectomy Int. J. Urol. (IF 2.6) Pub Date : 2024-02-01 Rikiya Taoka, Mikio Sugimoto
CONFLICT OF INTEREST STATEMENT None declared.
-
Editorial comment to Prognostic outcomes in patients with metastatic renal cell carcinoma receiving second-line treatment with tyrosine kinase inhibitor following first-line immune-oncology combination therapy Int. J. Urol. (IF 2.6) Pub Date : 2024-01-31 Takeshi Yuasa
CONFLICT OF INTEREST STATEMENT I received honoraria from Ono, Bristol Myers Squibb, MSD, Pfizer, Merk, Takeda, and Esai.
-
Surgical strategy for orthotopic kidney transplantation Int. J. Urol. (IF 2.6) Pub Date : 2024-01-31 Kiyohiko Hotta, Masayoshi Miura, Toshiaki Tanaka, Tatsu Tanabe, Naoya Masumori, Nobuo Shinohara
CONFLICT OF INTEREST STATEMENT All authors declare no conflicts of interest.
-
The DDD score outperforms the RENAL score in predicting high-grade renal cell carcinoma Int. J. Urol. (IF 2.6) Pub Date : 2024-01-30 Jun Zhu, Xi Pan, Jun-Yi Xie, Yu-Ke Chen, Yu Fan, Wei Yu, Li-Qun Zhou, Zhi-Song He, Zhong-Yuan Zhang
To explore the relationship between Fuhrman grade of renal cell carcinoma (RCC) and the DDD score.
-
Two-year follow-up comparing Rezūm therapy versus bipolar transurethral resection of the prostate for treating benign prostatic hyperplasia. A prospective randomized study Int. J. Urol. (IF 2.6) Pub Date : 2024-01-30 Mohamed Samir, Abd Allah Abd Elaal, Khaled Abdel Sattar Gad, Mohamed Wagieh Basyony
Comparison of the efficacy and safety of Rezūm therapy and bipolar transurethral resection of prostate (B-TURP) for the management of benign prostatic hyperplasia (BPH) of 50–120 g size.
-
Editorial Comment to Histological parameters and stromal desmoplastic status affecting accurate diagnosis of extraprostatic extension of prostate cancer using multi-parametric magnetic resonance imaging Int. J. Urol. (IF 2.6) Pub Date : 2024-01-29 Sunao Shoji
CONFLICT OF INTEREST STATEMENT None declared.
-
Editorial comment to Lower bleeding volume contributes to decreasing surgical site infection in radical cystectomy: A propensity score-matched comparison of open versus robot-assisted radical cystectomy Int. J. Urol. (IF 2.6) Pub Date : 2024-01-29 Yoshiki Hiyama
CONFLICT OF INTEREST STATEMENT None declared.
-
Editorial comment to “The clinical impact of ureteroscopy for upper tract urothelial carcinoma: A multicenter study” Int. J. Urol. (IF 2.6) Pub Date : 2024-01-29 Nozomi Hayakawa, Eiji Kikuchi
CONFLICT OF INTEREST STATEMENT Eiji Kikuchi received honoraria for lectures from MSD K.K. and Astellas Pharma Inc. Nozomi Hayakawa has no conflicts of interest to declare.
-
Increased 30-day complication rates associated with older age in children undergoing distal hypospadias repair Int. J. Urol. (IF 2.6) Pub Date : 2024-01-29 Mohamed Zouari, Manel Belhajmansour, Manar Hbaieb, Amel Ben Hamad, Mahdi Ben Dhaou, Riadh Mhiri
CONFLICT OF INTEREST STATEMENT We, the authors, have no financial or personal relationships with other people or organizations that could potentially and inappropriately influence our work and conclusions.
-
Editorial Comment from Dr Mori to Association between antibiotic use and subsequent risk of prostate cancer: A retrospective cohort study in South Korea Int. J. Urol. (IF 2.6) Pub Date : 2024-01-24 Keiichiro Mori
Prostate cancer is recognized as not only the most common of all solid cancers but also the second most common cause of cancer-related death in men.1 Several studies suggest that antibiotic use may affect overall cancer incidences, but the association between antibiotics and prostate cancer remains still unclear.2, 3 In this issue of the International Journal of Urology, Park and Hong et al. assessed
-
Development and preliminary evaluation of a novel procedure for creation of an ileal conduit stoma aimed at preventing parastomal hernia Int. J. Urol. (IF 2.6) Pub Date : 2024-01-18 Toshiaki Tanaka, Koji Yamasaki, Seisuke Nofuji, Takeshi Maehana, Tetsuya Shindo, Yuki Kyoda, Kohei Hashimoto, Ko Kobayashi, Naoya Masumori
Our previous study suggested that the operative procedure is critical for the development of parastomal hernia. We developed a novel procedure for the creation of an ileal conduit stoma to prevent parastomal hernia. Herein we evaluate the efficacy and safety of the procedure.
-
Longitudinal mortality risks and kidney functional outcomes in Japanese living kidney donors Int. J. Urol. (IF 2.6) Pub Date : 2024-01-19 Takayuki Hirose, Kiyohiko Hotta, Takahiro Osawa, Isao Yokota, Tasuku Inao, Tatsu Tanabe, Naoya Iwahara, Nobuo Shinohara
Previous studies suggested that living kidney donors do not have a higher risk of death or kidney failure than the general population. However, living kidney donor risk is controversial. Furthermore, only a few studies have evaluated long-term kidney function after kidney donation.
-
Prognostic outcomes in patients with metastatic renal cell carcinoma receiving second-line treatment with tyrosine kinase inhibitor following first-line immune-oncology combination therapy Int. J. Urol. (IF 2.6) Pub Date : 2024-01-19 Yuto Matsushita, Takahiro Kojima, Takahiro Osawa, Tomokazu Sazuka, Shingo Hatakeyama, Keisuke Goto, Kazuyuki Numakura, Kazutoshi Yamana, Shuya Kandori, Kazutoshi Fujita, Kosuke Ueda, Hajime Tanaka, Ryotaro Tomida, Toshifumi Kurahashi, Yukari Bando, Naotaka Nishiyama, Takahiro Kimura, Shimpei Yamashita, Hiroshi Kitamura, Hideaki Miyake
This study aimed to assess the prognostic outcomes in mRCC patients receiving second-line TKI following first-line IO combination therapy.
-
The harmful effects of overlooking acute bacterial prostatitis Int. J. Urol. (IF 2.6) Pub Date : 2024-01-18 Youngmin Yang, Katsumi Shigemura, Koki Maeda, Michika Moriwaki, Kuan-Chou Chen, Yuzo Nakano, Masato Fujisawa
Prostatitis is a major urological disease affecting 25%–50% of men over their lifetime. However, prostatitis is often overlooked in nonurologic departments due to its sometimes indeterminate symptoms. In this review, we describe how to recognize and treat acute bacterial prostatitis, which manifests as a clinical problem in other departments as well as urology, to help prevent this disease from being
-
Editorial Comment on “The clinical impact of ureteroscopy for upper tract urothelial carcinoma: A multicenter study” Int. J. Urol. (IF 2.6) Pub Date : 2024-01-16 Tomokazu Sazuka
CONFLICT OF INTEREST STATEMENT The authors declare no conflict of interest.
-
Editorial Comment to Validation of schedules for optimal PSA monitoring after radical prostatectomy Int. J. Urol. (IF 2.6) Pub Date : 2024-01-16 Kazuhiro Matsumoto
First and foremost, we extend our gratitude to Dr. Blas and colleagues for their invaluable validation of both our original and modified Keio PSA (prostate-specific antigen) follow-up schedule models.1 Radical prostatectomy stands as the primary treatment for clinically localized prostate cancer, with recurrence most commonly diagnosed through the detection of asymptomatic elevation in serum PSA levels
-
Editorial Comment on “Association between antibiotic use and subsequent risk of prostate cancer: A retrospective cohort study in South Korea” Int. J. Urol. (IF 2.6) Pub Date : 2024-01-12 Koji Hatano
CONFLICT OF INTEREST STATEMENT The authors declare no conflict of interest.
-
Long-term follow-up of congenital hydronephrosis in a single-center study Int. J. Urol. (IF 2.6) Pub Date : 2024-01-11 Yosuke Morizawa, Katsuya Aoki, Shinji Fukui, Mitsuru Tomizawa, Takuto Shimizu, Kenta Onishi, Shunta Hori, Daisuke Gotoh, Yasushi Nakai, Makito Miyake, Kazumasa Torimoto, Ken Fujimoto, Takeshi Otani, Kiyohide Fujimoto
Many congenital hydronephroses spontaneously resolve. This study evaluated a long-term follow-up of more than 4 years of patients with congenital hydronephrosis at a single center.
-
Editorial Comment on Does intensity-modulated radiation therapy by helical tomotherapy for prostate cancer increase the subsequent risk of bladder cancer? A propensity score-matched analysis Int. J. Urol. (IF 2.6) Pub Date : 2024-01-10 Osamu Ukimura
CONFLICT OF INTEREST STATEMENT Author for the editorial comment has no conflict of interest.
-
Early recovery of urinary continence after robot-assisted radical prostatectomy is associated with membranous urethra and neurovascular bundle preservation Int. J. Urol. (IF 2.6) Pub Date : 2024-01-09 Satoshi Ando, Toru Sugihara, Shiro Hinotsu, Hiroto Kishino, Daichi Hirata, Risako Watanabe, Atsushi Yanase, Hirotaka Yokoyama, Hayato Hoshina, Kaori Endo, Jun Kamei, Eiichiro Takaoka, Tetsuya Fujimura
We investigated the correlation between surgical outcomes and postoperative urinary continence recovery in robot-assisted radical prostatectomy (RARP).
-
The medical cost and outcome of desensitization protocol in kidney transplantation recipients with high immunological risks Int. J. Urol. (IF 2.6) Pub Date : 2024-01-09 Ryoichi Maenosono, Kohei Unagami, Rikako Oki, Yuya Fujiwara, Taro Banno, Daigo Okada, Takafumi Yagisawa, Taichi Kanzawa, Toshihito Hirai, Kazuya Omoto, Norio Hanafusa, Haruhito Azuma, Toshio Takagi, Hideki Ishida
Kidney transplantation is a well-established alternative in renal replacement therapy. Compared with hemodialysis, low-immunological-risk kidney transplantation can reduce the medical treatment costs associated with end-stage renal disease. However, there are few reports on whether high-immunological-risk kidney transplantation reduces the financial burden on governments. We investigated the medical
-
Clinical features and oncological outcomes of bladder cancer microsatellite instability Int. J. Urol. (IF 2.6) Pub Date : 2024-01-09 Shohei Nagakawa, Masaki Shiota, Dai Takamatsu, Shigehiro Tsukahara, Takashi Mastumoto, Leandro Blas, Junichi Inokuchi, Yoshihiro Oda, Masatoshi Eto
Excellent anticancer effect for solid tumors with microsatellite instability (MSI)-high by anti-PD-1 antibody has been reported. In this study, we investigated the clinical impact of MSI status in bladder cancer.
-
Does intensity-modulated radiation therapy by helical tomotherapy for prostate cancer increase the subsequent risk of bladder cancer? A propensity score-matched analysis Int. J. Urol. (IF 2.6) Pub Date : 2024-01-09 Fumio Tsukuda, Yasunari Tanaka, Shuichiro Narita, Toshihiro Shimizu, Shu Nakasuka, Kiichi Hagiwara, Noboru Sakamoto, Kawano Toshihiro, Yutaka Horiguchi, Shoji Koga
This study aimed to evaluate the risk of bladder cancer after intensity-modulated radiation therapy (IMRT) using helical tomotherapy for prostate cancer in comparison to the risk post-radical prostatectomy (RP) using propensity score-matched analysis and to assess the risk factors for bladder cancer.
-
Novel image-guided marker aimed at organ-preserving therapies for prostate cancer Int. J. Urol. (IF 2.6) Pub Date : 2024-01-09 Koji Okihara, Takashi Ueda, Atsuko Fujihara, Takumi Shiraishi, Hiroshi Iwasaki, Takeshi Nomoto, Koji Masui, Toshiko Ito-Ihara, Eri Hara, Ryusuke Nakai, Tsuyoshi Shiina, Osamu Ukimura
We developed fiducial imaging-guidance markers for the prostate with less imaging artifacts than currently commercially available markers. The aim of this study was to evaluate the imaging artifacts and potential usefulness and safety of these novel fiducial imaging markers in preclinical experiments.